Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512621006433 |
_version_ | 1819020506803732480 |
---|---|
author | Jose W. Ricardo, MD Shari R. Lipner, MD, PhD |
author_facet | Jose W. Ricardo, MD Shari R. Lipner, MD, PhD |
author_sort | Jose W. Ricardo, MD |
collection | DOAJ |
first_indexed | 2024-12-21T03:52:18Z |
format | Article |
id | doaj.art-fa6f34f66f3a4b9699aadca29a9062f7 |
institution | Directory Open Access Journal |
issn | 2352-5126 |
language | English |
last_indexed | 2024-12-21T03:52:18Z |
publishDate | 2021-11-01 |
publisher | Elsevier |
record_format | Article |
series | JAAD Case Reports |
spelling | doaj.art-fa6f34f66f3a4b9699aadca29a9062f72022-12-21T19:16:57ZengElsevierJAAD Case Reports2352-51262021-11-01171820Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccineJose W. Ricardo, MD0Shari R. Lipner, MD, PhD1Department of Dermatology, Weill Cornell Medicine, New York, New YorkCorrespondence to: Shari R. Lipner, MD, PhD, Department of Dermatology, Weill Cornell Medicine, 1305 York Avenue, New York, NY 10021.; Department of Dermatology, Weill Cornell Medicine, New York, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2352512621006433adverse reactionBeau linesCOVID-19nail psoriasisnailsonycholysis |
spellingShingle | Jose W. Ricardo, MD Shari R. Lipner, MD, PhD Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine JAAD Case Reports adverse reaction Beau lines COVID-19 nail psoriasis nails onycholysis |
title | Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine |
title_full | Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine |
title_fullStr | Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine |
title_full_unstemmed | Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine |
title_short | Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine |
title_sort | case of de novo nail psoriasis triggered by the second dose of pfizer biontech bnt162b2 covid 19 messenger rna vaccine |
topic | adverse reaction Beau lines COVID-19 nail psoriasis nails onycholysis |
url | http://www.sciencedirect.com/science/article/pii/S2352512621006433 |
work_keys_str_mv | AT josewricardomd caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine AT sharirlipnermdphd caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine |